title: A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
abstract: We have shown that Alox5 is a critical regulator of leukemia stem cells (LSCs) in a BCR-ABL-induced chronic myeloid leukemia (CML) mouse model, and we hypothesize that the Alox5 pathway represents a major molecular network that regulates LSC function. Therefore, we sought to dissect this pathway by comparing the gene expression profiles of wild type and Alox5(-/-) LSCs. DNA microarray analysis revealed a small group of candidate genes that exhibited changes in the levels of transcription in the absence of Alox5 expression. In particular, we noted that the expression of the Msr1 gene was upregulated in Alox5(-/-) LSCs, suggesting that Msr1 suppresses the proliferation of LSCs. Using CML mouse model, we show that Msr1 is downregulated by BCR-ABL and this down-regulation is partially restored by Alox5 deletion, and that Msr1 deletion causes acceleration of CML development. Moreover, Msr1 deletion markedly increases LSC function through its effects on cell cycle progression and apoptosis. We also show that Msr1 affects CML development by regulating the PI3K-AKT pathway and β-Catenin. Together, these results demonstrate that Msr1 suppresses LSCs and CML development. The enhancement of the tumor suppressor function of Msr1 may be of significance in the development of novel therapeutic strategies for CML.
authors: Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
authors: Yaoyu
authors: Y
authors: Chen
authors: Con
authors: C
authors: Sullivan
authors: Cong
authors: C
authors: Peng
authors: Yi
authors: Y
authors: Shan
authors: Yiguo
authors: Y
authors: Hu
authors: Dongguang
authors: D
authors: Li
authors: Shaoguang
authors: S
authors: Li
references: Nature. 2010 Feb 4;463(7281):676-80
references: 20130650
references: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16870-5
references: 17077147
references: Cell. 2007 Jan 26;128(2):325-39
references: 17254970
references: Blood. 1994 Jan 1;83(1):43-50
references: 8274751
references: J Clin Invest. 2001 Sep;108(5):649-54
references: 11544267
references: Nature. 2009 Apr 9;458(7239):776-9
references: 19169242
references: J Exp Med. 1999 May 3;189(9):1399-412
references: 10224280
references: Nature. 2003 May 15;423(6937):302-5
references: 12714971
references: EMBO J. 2001 Dec 3;20(23):6793-804
references: 11726515
references: Genes Dev. 2005 Jun 15;19(12):1432-7
references: 15964994
references: Nature. 2006 May 25;441(7092):475-82
references: 16598206
references: Curr Opin Genet Dev. 2003 Feb;13(1):77-83
references: 12573439
references: Arterioscler Thromb Vasc Biol. 1999 Aug;19(8):1872-80
references: 10446065
references: Nature. 2010 Aug 5;466(7307):765-8
references: 20639863
references: Blood. 2010 Jan 21;115(3):626-35
references: 19965668
references: Nat Genet. 2009 Jul;41(7):783-92
references: 19503090
references: Blood. 2007 Jul 15;110(2):678-85
references: 17395781
references: Cancer Cell. 2007 Dec;12(6):528-41
references: 18068630
references: Cancer Cell. 2005 Nov;8(5):355-68
references: 16286244
references: Nature. 2001 Nov 1;414(6859):105-11
references: 11689955
references: Nature. 2008 Jun 19;453(7198):1072-8
references: 18469801
references: Nat Genet. 2002 Oct;32(2):321-5
references: 12244320
references: Leukemia. 2009 Jan;23(1):109-16
references: 18818703
references: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7444-9
references: 16651519
references: Nature. 1990 Feb 8;343(6258):570-2
references: 2300208
references: Nature. 1994 Nov 10;372(6502):179-82
references: 7969451
references: Nat Genet. 2004 May;36(5):453-61
references: 15098032
references: Curr Opin Cell Biol. 2004 Dec;16(6):700-7
references: 15530784